Large electrostrain in Bi1/2Na1/2TiO3-based relaxor ferroelectrics: A case study of Bi1/2Na1/2TiO3-Bi1/2K1/2TiO3-Bi(Ni2/3Nb1/3)O3 ceramics

Guangzhi Dong,Huiqing Fan,Laijun Liu,Pengrong Ren,Zhenxiang Cheng,Shujun Zhang

DOI: https://doi.org/10.1016/j.jmat.2020.11.002

IF: 8.589

2021-05-01

Journal of Materiomics

Abstract:(1-x)(0.8Bi1/2Na1/2TiO3-0.2Bi1/2K1/2TiO3)-xBi(Ni2/3Nb1/3)O3 (BNKT-xBNN) solid solution ceramics were fabricated by high temperature solid-state reaction method. All the compositions possess relaxor ferroelectric features, among which the ergodic BNKT-0.02BNN exhibits large repeatable electrostrain value S uni = 0.51% at electric field of 65 kV/cm, with high piezoelectric stain coefficient d 33∗ of 890 pm/V at 45 kV/cm, while the non-ergodic compositions present unrepeatable large strain response. Based on the electric field-composition phase diagram, the repeatability of strain response in ergodic compositions can be attributed to the reversible electric-field-induced phase transition. In addition, the effects of BNN contents on the macroscopic strain properties are explored by analyzing the existing states of the polar regions with corresponding thermal evolutions and electric-field-induced phase transitions. This research is expected to guide the design of lead free relaxor ferroelectric materials with desired electrostrain properties.

materials science, multidisciplinary,chemistry, physical,physics, applied

What problem does this paper attempt to address?

The paper primarily explores the impact of gender on the virological response rate in genotype 1 chronic hepatitis C (CHC) patients treated with peginterferon alpha-2a and ribavirin.

The research background includes:
- Chronic hepatitis C is a global health issue.
- There are significant differences in the rate of fibrosis progression in chronic hepatitis C between males and females, with males progressing faster.
- Estrogen and its receptors may influence the progression of liver disease.
- Females have poorer tolerance to ribavirin, especially in older women, where lower cumulative doses lead to higher relapse rates and lower sustained virological response (SVR) rates.

The study design employed a matched retrospective cohort study method, selecting 630 genotype 1 chronic hepatitis C patients from a database, divided into three age groups: <40 years, 40-50 years, and 51-60 years. The study compared the drug dose acceptance and virological response rates between male and female patients in each group.

The main conclusions are as follows:
- In the <40 years patient group, females had a higher SVR rate than males.
- In the 40-50 years patient group, the SVR rates were similar between males and females.
- In the 51-60 years patient group, females had a lower SVR rate than males.
- In the 51-60 years patient group, independent predictors of SVR included gender, completion of at least 80% of the planned ribavirin dose, and the presence of rapid virological response (RVR).

In summary, this study aims to evaluate how gender affects the virological response in chronic hepatitis C patients of different age groups receiving combination therapy with peginterferon alpha-2a and ribavirin.